Teva introduces a generic of Acanya

Print Friendly, PDF & Email

JERUSALEM, Israel —Teva Pharmaceuticals announces the introduction and availability of clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. This product is AB rated and bioequivalent to Acanya (Clindamycin Phosphate and Benzoyl Peroxide) Gel.

Teva Pharmaceuticals USA, Inc. is a wholly-owned subsidiary of Israeli-based Teva Pharmaceutical Industries Ltd., one of the leading pharmaceutical companies in the world. Teva leads the U.S. generic pharmaceutical market in total and new prescriptions. One out of every eight generic prescriptions filled in the U.S. is filled with a Teva product.



Comments are closed.